Global Biosimilars Market Size and Growth Analysis | Forecast 2026 to 2035 By Type (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins</li>), Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Others)
January 2026
Healthcare
Pages: 110
ID: MRS2033
The Global Biosimilars Market was valued at USD million in 2025, reflecting a CAGR of % from 2026 to 2035. It is projected to grow to USD million by 2035.
Global Biosimilars Market Overview:
A biosimilar is an identical copy of a drug that is manufactured by some other company. The biosimilar is different from genetic drugs owing to its higher degree of molecular complexity. This report suggests that the global biosimilars market is anticipated to expand at a moderate CAGR across the evaluation period. In addition, the market is poised to reach a decent valuation by the close of the review period.
The intensified competition in the drug manufacturing industry is anticipated to drive growth of the biosimilars market in the nearby future. The rising demand for cost-cutting in the healthcare industry is likely to encourage the adoption of the product, thus, supporting expansion of biosimilars market.
This biosimilars market report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2035.
Biosimilars Market Segmentation:
The global biosimilars market is studied for a diverse segmentation that is based on type, application, and region. This segmentation is conducted with the intention of providing the reader of this report with intricate market trends that may influence the decisions exponentially. By type, the global biosimilars market is segmented into recombinant non-glycosylated proteins (insulin, rhgh, interferon), recombinant glycosylated proteins. Based on application, the global biosimilars market is segmented into oncology, blood disorders, growth hormonal deficiency, chronic and autoimmune disorders, others.
Market Segment By Type:
Type-wise breakup of the global biosimilars market
- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- Recombinant Glycosylated Proteins
By Application:
Application-wise breakup of the global biosimilars market
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Others
Biosimilars Market: Regional Analysis
The biosimilars market is segmented on the basis of geography into:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
The geographical analysis of the global biosimilars market is covered on two levels – regional and country basis. The key regions identified are North America, South America, Europe, Asia Pacific, the Rest of the World (RoW). Europe is anticipated to play a substantial role in the market development. The regions is a home to some of the key players that are poised to expand biosimilars market over the next couple of years. However, the impact of Brexit on the regional biosimilars market is expected to pose challenges to players. In a recent Mi 10th Annual Biosimilars Conference, which was held in London, it has been discussed that the Medicines and Healthcare Products Regulatory Agency (MHRA) pf the UK will receive marketing authorizations on the exit day. It is poised to influence the market positively over the next couple of years.
North America is one of the prime regional segments of the biosimilars market. It is expected that the region is set to observe increase in production levels in the years to come. In addition, the entry of new players is about the accelerate the growth rate of the biosimilars market in the region across the evaluation period.
Asia Pacific biosimilars market is also projected to witness substantial compound annual growth rate over the next few years. The growth is likely to be backed by the rising patient population and expansion of the healthcare industry. Also, the boost in the medical tourism industry is anticipated to attract investments, thus, motivating growth of the biosimilars market.
North America Biosimilars Market Revenue And Forecasts TO 2035
The North America Regional and Country-level Revenue And Forecast Analysis:
North America Biosimilars Industry Overview
North America Biosimilars Industry Forecasts and Analysis
North America Biosimilars Industry Forecasts and Analysis - By Type
North America Biosimilars Industry Forecasts and Analysis - By Application
North America Biosimilars Industry Forecasts and Analysis - By Countries
United States Biosimilars Market
United States Biosimilars by Type
United States Biosimilars by Application
Canada Biosimilars Market
Canada Biosimilars by Type
Canada Biosimilars by Application
Mexico Biosimilars Market
Mexico Biosimilars by Type
Mexico Biosimilars by Application
Europe Biosimilars Market Revenue And Forecasts TO 2035
The Europe Regional and Country-level Revenue And Forecast Analysis:
Europe Biosimilars Industry Overview
Europe Biosimilars Industry Forecasts and Analysis
Europe Biosimilars Industry Forecasts and Analysis - By Type
Europe Biosimilars Industry Forecasts and Analysis - By Application
Europe Biosimilars Industry Forecasts and Analysis - By Countries
Germany Biosimilars Market
Germany Biosimilars by Type
Germany Biosimilars by Application
France Biosimilars Market
France Biosimilars by Type
France Biosimilars by Application
Italy Biosimilars Market
Italy Biosimilars by Type
Italy Biosimilars by Application
United Kingdom Biosimilars Market
United Kingdom Biosimilars by Type
United Kingdom Biosimilars by Application
Rest of Europe Biosimilars Market
Rest of Europe Biosimilars by Type
Rest of Europe Biosimilars by Application
Asia-Pacific Biosimilars Market Revenue And Forecasts TO 2035
The Asia-Pacific Regional and Country-level Revenue And Forecast Analysis:
Asia-Pacific Biosimilars Industry Overview
Asia-Pacific Biosimilars Industry Forecasts and Analysis
Asia-Pacific Biosimilars Industry Forecasts and Analysis - By Type
Asia-Pacific Biosimilars Industry Forecasts and Analysis - By Application
Asia-Pacific Biosimilars Industry Forecasts and Analysis - By Countries
Australia Biosimilars Market
Australia Biosimilars by Type
Australia Biosimilars by Application
China Biosimilars Market
China Biosimilars by Type
China Biosimilars by Application
India Biosimilars Market
India Biosimilars by Type
India Biosimilars by Application
Japan Biosimilars Market
Japan Biosimilars by Type
Japan Biosimilars by Application
South Korea Biosimilars Market
South Korea Biosimilars by Type
South Korea Biosimilars by Application
Rest of Asia-Pacific Biosimilars Market
Rest of Asia-Pacific Biosimilars Market by Type
Rest of Asia-Pacific Biosimilars Market by Application
(Note: Rest of all the regions mentioned in this report will be presented using the above-mentioned parameters.)
Competitive Landscape
This report profiles key players in the global biosimilars market based on the following parameters, company overview, key facts, business description, financial overview (sales quantity, revenue, price, gross margin), products and services, geographical presence, SWOT analysis, and key developments. These companies collectively hold the largest market share and dictate industry trends. The following are the leading companies in the Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan, Eli Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Amgen, Celltrion, Samsung Biologics, Roche, Probiomed, Apotex, Chong Kun Dang, JCR Pharmaceuticals, Gan & Lee Pharmaceuticals, Gedeon Richter, Biocad, Coherus Bioscience, Stada Arzneimittel AG
Company Profiles:
Major Companies Covered in the biosimilars market:
- Pfizer
- Novartis
- Biocon
- Biogen
- Fresenius Kabi AG
- Boehringer Ingelheim
- Merck KgaA
- Mylan
- Eli Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Amgen
- Celltrion
- Samsung Biologics
- Roche
- Probiomed
- Apotex
- Chong Kun Dang
- JCR Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Gedeon Richter
- Biocad
- Coherus Bioscience
- Stada Arzneimittel AG
Biosimilars Market Scope
| Report Attribute | Details |
| Report Objective | To provide comprehensive insights into the biosimilars market size, trends, segmentation, regional dynamics, and competitive landscape. |
| Base Year | 2025 |
| Historical Period | 2020 to 2024 |
| Forecast Period | 2026 to 2035 |
| Market Size In 2025 | USD million |
| Market Size In 2035 | USD million |
| Compound Annual Growth Rate (CAGR) | % |
| Segments |
By Product Type
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), Recombinant Glycosylated Proteins
By Application
Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Others |
| Regions Covered |
|
| Companies Profiled | Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan, Eli Lilly, Teva Pharmaceutical, Dr. Reddy's Laboratories, Amgen, Celltrion, Samsung Biologics, Roche, Probiomed, Apotex, Chong Kun Dang, JCR Pharmaceuticals, Gan & Lee Pharmaceuticals, Gedeon Richter, Biocad, Coherus Bioscience, Stada Arzneimittel AG |
Frequently Asked Questions
Related Reports
Recent Reports
Global Animation and VFX Design Software Market Size and Growth Analysis 2020 to 2025 | Forecast 2026 to 2035
Global Animation and VFX Design Software Market is valued at USD million in 2025 and has witnessed a CAGR of % during 2020-2025. The market is anticipated to further register a CAGR of over % during the forecast period of 2026 to 2035
Global Anti-Asthmatics and COPD Drugs Market Size and Growth Analysis 2020 to 2025 | Forecast 2026 to 2035
Global Anti-Asthmatics and COPD Drugs Market is valued at USD million in 2025 and has witnessed a CAGR of % during 2020-2025. The market is anticipated to further register a CAGR of over % during the forecast period of 2026 to 2035